Abbott Laboratories insider trading
Health Care · Strong buyingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 4 Abbott Laboratories insiders reported open-market purchases totaling $4.4M, while 7 insiders reported sales totaling $47.5M. The most recent cluster buy began on Apr 23, 2026, when 3 insiders bought a combined $1.3M. Among insiders with enough purchase history to measure, Daniel J Starks (Director) has the highest Insider Score at 35. 0 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 44 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 3SEC | John A. Mccoy Jr.President | Sell | 27 | $109.54 | $3K | -8.6% | — |
| Aug 27SEC | Robert B FordCEO, Chair | Sell | 218,535 | $115.57 | $25.3M | -13.4% | — |
| Aug 27SEC | Robert B FordCEO, Chair | Sell | 180,297 | $116.19 | $20.9M | -13.8% | — |
| Aug 13SEC | Louis H. MorronePresident | Sell | 5,850 | $109.83 | $643K | -8.9% | — |
| Jun 18SEC | John G StrattonDirector | Buy | 2,000 | $86.82 | $174K | +15.3% | — |
| Apr 28SEC | Daniel J StarksDirector | Buy | 10,000 | $92.65 | $927K | +8.0% | 35 |
| Apr 27SEC | Philip P BoudreauCFO | Buy | 2,200 | $91.50 | $201K | +9.4% | — |
| Mar 3SEC | Louis H. MorronePresident | Sell | 1,144 | $115.58 | $132K | -13.4% | — |
| Mar 3SEC | Daniel Gesua Sive SalvadoriPresident | Sell | 885 | $115.58 | $102K | -13.4% | — |
| Mar 3SEC | Eric ShroffPresident | Sell | 709 | $115.58 | $82K | -13.4% | — |
| Mar 3SEC | Mary K MorelandPresident | Sell | 613 | $115.58 | $71K | -13.4% | — |
| Mar 3SEC | John A. Mccoy Jr.President | Sell | 585 | $115.58 | $68K | -13.4% | — |
| Mar 3SEC | Elizabeth C. CushmanEvp, Gc And Secretary | Sell | 263 | $115.58 | $30K | -13.4% | — |
| Feb 6SEC | Daniel J StarksDirector | Buy | 5,033 | $108.33 | $545K | -7.6% | 35 |
| Feb 6SEC | Daniel J StarksDirector | Buy | 4,967 | $109.14 | $542K | -8.3% | 35 |
| Jan 26SEC | Robert B FordCEO, Chair | Buy | 18,800 | $107.13 | $2.0M | -6.6% | — |
| Nov 25SEC | Eric ShroffPresident | Sell | 1,586 | $128.02 | $203K | -21.8% | — |
Insiders at Abbott Laboratories
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Robert B FordCEO, Chair | $2.0M | $46.2M | Aug 27, 2026 | — |
| Daniel J StarksDirector | $2.0M | — | Apr 28, 2026 | 35 |
| Louis H. MorronePresident | — | $775K | Aug 13, 2026 | — |
| Philip P BoudreauCFO | $201K | — | Sep 3, 2026 | — |
| John G StrattonDirector | $174K | — | Jun 18, 2026 | — |
| Eric ShroffPresident | — | $285K | Mar 3, 2026 | — |
| Daniel Gesua Sive SalvadoriPresident | — | $102K | Mar 3, 2026 | — |
| Mary K MorelandPresident | — | $71K | Apr 29, 2026 | — |
| John A. Mccoy Jr.President | — | $71K | Sep 3, 2026 | — |
| Elizabeth C. CushmanEvp, Gc And Secretary | — | $30K | Jun 29, 2026 | — |
| Kevin T ConroyDirector | — | — | Sep 25, 2026 | — |
| Nancy MckinstryDirector | — | — | Apr 28, 2026 | — |
| Michael O'gradyDirector | — | — | Apr 28, 2026 | — |
| Sally E. BlountDirector | — | — | Apr 28, 2026 | — |
| Michael F RomanDirector | — | — | Apr 28, 2026 | — |
| Michelle KumbierDirector | — | — | Apr 28, 2026 | — |
| Claire Babineaux-fontenotDirector | — | — | Apr 28, 2026 | — |
| Darren W McdewDirector | — | — | Apr 28, 2026 | — |
| Patricia Paola GonzalezDirector | — | — | Apr 28, 2026 | — |
| Nita AhujaDirector | — | — | Apr 28, 2026 | — |
| Jacob A OrvillePresident | — | — | Mar 25, 2026 | — |
| Lisa D EarnhardtPresident | — | — | Mar 3, 2026 | — |
| Christopher J ScogginsPresident | — | — | Mar 3, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about ABT insiders
Are Abbott Laboratories insiders buying ABT stock?
In the past 12 months, 4 insiders reported open-market purchases of ABT worth $4.4M. The latest was Director John G Stratton bought $174K of ABT at $86.82 — first open-market purchase in our records.
Are Abbott Laboratories insiders selling ABT stock?
7 insiders reported sales worth $47.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.